0000899243-18-031698.txt : 20181226
0000899243-18-031698.hdr.sgml : 20181226
20181226160606
ACCESSION NUMBER: 0000899243-18-031698
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181222
FILED AS OF DATE: 20181226
DATE AS OF CHANGE: 20181226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ross Leonard S
CENTRAL INDEX KEY: 0001458753
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 181252751
MAIL ADDRESS:
STREET 1: C/O PSIVIDA CORP
STREET 2: 400 PLEASANT STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-22
0
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001458753
Ross Leonard S
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
0
1
0
0
See Remarks
Common Stock
2018-12-22
4
M
0
62892
A
94709
D
Common Stock
2018-12-22
4
F
0
18522
1.65
D
76187
D
Restricted stock units
2018-12-22
4
M
0
62892
0.00
D
Common Stock
62892
0
D
Restricted stock units convert into common stock on a one-for-one basis.
No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on December 21, 2018.
On December 22, 2017, the reporting person was granted 62,892 restricted stock units, vesting in full on the first anniversary of the grant date.
Vice President of Finance and Chief Accounting Officer
/s/ John Mercer, Attorney-in-Fact
2018-12-26